Paper8323396
Baseline plasma fibrinolysis and its correlation with clinical manifestations in patients with Raynaud's phenomenon.
Lau CS and 3 others. Ann Rheum Dis, 1993. Cited by 23 papers, by iCite.
Cite this record
ConductScience Library. Baseline plasma fibrinolysis and its correlation with clinical manifestations in patients with Raynaud's phenomenon. Papers, record 8323396. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8323396
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Baseline plasma fibrinolysis and its correlation with clinical manifestations in patients with Raynaud's phenomenon.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fibrinolysis | Major topic |
| Raynaud Disease | Major topic |
| Arteriosclerosis | |
| Connective Tissue Diseases | |
| Female | |
| Fibrinogen | |
| Fibrinopeptide A | |
| Humans | |
| Male | |
| Middle Aged | |
| von Willebrand Factor |
Source PubMed
References16
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 5775073 | Blood fibrinolytic activity in diseases of small blood vessels and the effect of low molecular weight dextran. | Br J Dermatol | 1969 | https://conductscience.org/library/papers/5775073 | PubMed |
| 2 | 14289442 | BLOOD VISCOSITY AND RAYNAUD'S DISEASE. | Lancet | 1965 | https://conductscience.org/library/papers/14289442 | PubMed |
| 3 | 58309 | Abnormal blood viscosity in Raynaud's phenomenon. | Lancet | 1976 | https://conductscience.org/library/papers/58309 | PubMed |
| 4 | 698554 | Treatment of Raynaud's phenomenon by fibrinolytic enhancement. | Br Med J | 1978 | https://conductscience.org/library/papers/698554 | PubMed |
| 5 | 7378088 | Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. | Arthritis Rheum | 1980 | https://conductscience.org/library/papers/7378088 | PubMed |
| 6 | 7138600 | The 1982 revised criteria for the classification of systemic lupus erythematosus. | Arthritis Rheum | 1982 | https://conductscience.org/library/papers/7138600 | PubMed |
| 7 | 6422555 | Tissue plasminogen activator: chemical and physiological aspects. | Semin Thromb Hemost | 1984 | https://conductscience.org/library/papers/6422555 | PubMed |
| 8 | 3118442 | Vascular damage and factor-VIII-related antigen in the rheumatic diseases. | Rheumatol Int | 1987 | https://conductscience.org/library/papers/3118442 | PubMed |
| 9 | 3124290 | The extrinsic fibrinolytic system in survivors of myocardial infarction. | Thromb Res | 1987 | https://conductscience.org/library/papers/3124290 | PubMed |
| 10 | 3358796 | The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. | Arthritis Rheum | 1988 | https://conductscience.org/library/papers/3358796 | PubMed |
| 11 | 3056781 | Late-onset Raynaud's syndrome: diagnostic and therapeutic considerations. | Geriatrics | 1988 | https://conductscience.org/library/papers/3056781 | PubMed |
| 12 | 2536282 | Increased alpha-adrenergic responsiveness in idiopathic Raynaud's disease. | Arthritis Rheum | 1989 | https://conductscience.org/library/papers/2536282 | PubMed |
| 13 | 2542629 | The importance of presynaptic beta receptors in Raynaud's disease. | J Vasc Surg | 1989 | https://conductscience.org/library/papers/2542629 | PubMed |
| 14 | 1994867 | A controlled study of stanozolol in primary Raynaud's phenomenon and systemic sclerosis. | Ann Rheum Dis | 1991 | https://conductscience.org/library/papers/1994867 | PubMed |
| 15 | 1596699 | Further evidence of increased polymorphonuclear cell activity in patients with Raynaud's phenomenon. | Br J Rheumatol | 1992 | https://conductscience.org/library/papers/1596699 | PubMed |
| 17 | 4238527 | High molecular weight derivatives of human fibrinogen produced by plasmin. I. Physicochemical and immunological characterization. | J Biol Chem | 1969 | https://conductscience.org/library/papers/4238527 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37089827 | Raynaud's Phenomenon: A Brush Up! | Indian Dermatol Online J | 2023 | https://conductscience.org/library/papers/37089827 | PubMed |
| 27407233 | Raynaud's phenomenon: new aspects of pathogenesis and the role of nailfold videocapillaroscopy. | Reumatologia | 2015 | https://conductscience.org/library/papers/27407233 | PubMed |
| 22108676 | Association of von Willebrand factor and fibrinogen plasma levels with primary Raynaud's phenomenon in male and female patients. | Rheumatol Int | 2013 | https://conductscience.org/library/papers/22108676 | PubMed |
| 10627425 | Macrovascular disease and systemic sclerosis. | Ann Rheum Dis | 2000 | https://conductscience.org/library/papers/10627425 | PubMed |
| 8712862 | Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis. | Ann Rheum Dis | 1996 | https://conductscience.org/library/papers/8712862 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| FGB | 2244 | PubTator's text mining | https://conductscience.org/library/genes/2244 | NCBI Gene |
| PLG | 5340 | PubTator's text mining | https://conductscience.org/library/genes/5340 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8323396
GET https://conductscience.org/api/papers/v1/8323396/authors